Document is current
Any future updates will be listed below
-
Authors
Ricchiuti, G.
Taillieu, A.
Tuerlinckx, E.
Prinsen, J.
Debbaut, E.
Steyaert, J.
Boets, B.
Alaerts, Kaat
-
Funding
Funding for this research was provided by:
Fonds Wetenschappelijk Onderzoek (FWO; 11PW324N)
Flanders Fund for Scientific Research (FWO; 1257621N, FWO-TBM T001821N, FWO-TBM T001821N, FWO-TBM T001821N)
Onderzoeksraad, KU Leuven (C24M/21/045)
- License Information
-
More Information
Article History
Received: 30 January 2025
Accepted: 17 February 2025
First Online: 3 March 2025
Declarations
:
: Written informed consent will be obtained from the child’s parents or legal guardians prior to study enrollment. Consent forms and study design were approved by the Ethics Committee for Biomedical Research at the University of Leuven, KU Leuven (S66832) in accordance with The Code of Ethics of the World Medical Association (Declaration of Helsinki and its later amendments). The trial will be monitored by the Clinical Trial Center at the University Hospital of Leuven. All trial staff obtained Good Clinical Practice certification and will be trained in the study protocol.
: Not applicable.
: The authors declare no competing interests.
